Cameron Durrant

Currently holds a position at Humanigen Inc

Position	Company	Period
Chairman of the Board, Chief Executive Officer	Humanigen Inc	Sept. 5, 2017 -
Lead Independent Director	Immune Pharmaceuticals Inc	Jan. 21, 2015 - Sept. 10, 2018
Chairman of the Board, Chief Executive Officer, interim Chief Financial Officer	Humanigen Inc	Aug. 11, 2017 - Sept. 5, 2017
Chairman of the Board, Chief Executive Officer	Humanigen Inc	March 3, 2016 - Aug. 11, 2017
Independent Chairman of the Board	Humanigen Inc	Jan. 11, 2016 - March 3, 2016
Independent Director	Immune Pharmaceuticals Inc	July 10, 2014 - Jan. 21, 2015
President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, Director	OncBioMune Pharmaceuticals Inc	Oct. 31, 2012 - Aug. 7, 2013
President, Chief Executive Officer, Director	OncBioMune Pharmaceuticals Inc	Nov. 17, 2010 - Oct. 31, 2012

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-03-04	2022-03-02	Humanigen Inc (HGEN)	B Purchase	43,453 +35.9% 219.17 US$3,940,924	43,453 +35.9%	219.17	US$3,940,924
2021-06-16	2021-06-14	Humanigen Inc (HGEN)	S Sale	12,805 +17.7% 214.82 US$4,684,803	12,805 +17.7%	214.82	US$4,684,803
2021-06-16	2021-06-14	Humanigen Inc (HGEN)	S Sale	60,617 -36.0% 164.33 US$2,489,513	60,617 -36.0%	164.33	US$2,489,513
2021-06-16	2021-06-14	Humanigen Inc (HGEN)	S Sale	26,441 -23.7% 20.60 US$544,685	26,441 -23.7%	20.60	US$544,685